Advertisement

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase

Yok-Lam Kwong, Thomas S.Y. Chan, Daryl Tan, Seok Jin Kim, Li-Mei Poon, Benjamin Mow, Pek-Lan Khong, Florence Loong, Rex Au-Yeung, Jabed Iqbal, Colin Phipps and Eric Tse

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted December 13, 2016.
  • Accepted January 24, 2017.
  • Published online February 10, 2017.


Contributors 
  • Yok-Lam Kwong, 1 Department of Medicine, Queen Mary Hospital, Hong Kong;
  • Thomas S.Y. Chan, 1 Department of Medicine, Queen Mary Hospital, Hong Kong;
  • Daryl Tan, 2 Raffles Cancer Center, Raffles Hospital, Singapore;
  • Seok Jin Kim, 3 Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of;
  • Li-Mei Poon, 4 Department of Hematology/Oncology, National University Cancer Institute, Singapore;
  • Benjamin Mow, 5 Mow Blood and Cancer Clinic, Mount Elizabeth Medical Center, Singapore;
  • Pek-Lan Khong, 6 Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong;
  • Florence Loong, 7 Department of Pathology, Queen Mary Hospital, Hong Kong;
  • Rex Au-Yeung, 7 Department of Pathology, Queen Mary Hospital, Hong Kong;
  • Jabed Iqbal, 8 Department of Anatomic Pathology, Singapore General Hospital, Singapore;
  • Colin Phipps, 9 Department of Haematology, Singapore General Hospital, Singapore
  • Eric Tse, 1 Department of Medicine, Queen Mary Hospital, Hong Kong;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output